Hans georg dederer (49 Ergebnisse)

Zustand: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.

Zustand: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.

Zustand: as new. Wie neu/Like new.

Zustand: Gut. 11., völlig neu bearbeitete Auflage. 393 Seiten; Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber und kann entsprechende Merkmale aufweisen (Rückenschild, Instituts-Stempel.). Sprache: Deutsch Gewicht in Gramm: 820 gebundene Ausgabe, Bibliothekseinband. …

Zustand: Brand New. 430 pages. German language. 6.81x1.18x9.41 inches. In Stock.

weicher Einband. 142 S. OKt. 1. Aufl. Archiv-Stempel des Alber-Verlages auf dem Kopfschnitt; sonst sehr guter Zustand. Auflage: 1 ISBN 9783495481950.

Softcover/Paperback. Zustand: Sehr gut. 142 Seiten. Archivstempel und -zettel innen. Einband minimal berieben, ansonsten sehr gut erhalten. 9783495481950 Sprache: Deutsch Gewicht in Gramm: 1200 8Ethik in den Biowissenschaften, Band 3.).

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume elucidates the pivotal ethical and legal issues arising from the use of brain organoids for research, therapeutic and enhancement purposes.The function of the human brain is still a mystery. Until recently, only post-mortem tissue was available for a structural examination of the brain. Consequently, the examination results could only reflect the state at the end of life. However, in order to better understand the development and function of the human brain, dynamic and functional investigations of different human brain cells are necessary. This is where brain organoids, artificially grown in vitro miniature brains, provide the opportunity for more flexible research scenarios.At the same time, however, the use of brain organoids in research and therapy raises the question of how these new entities are to be treated from an ethical and legal point of view. Against this background, this volume aims at clarifying the normative implications of the use of brain organoids in research and therapy. The ethical reflections on the status of brain organoids, informed consent, human-to-animal chimeras and neuro-enhancement are mirrored by corresponding legal analyses. The ethical and legal assessments are preceded by an introduction to the scientific and medical background of the brain organoid technology. A final chapter will be devoted to the issue of whether international harmonization of normative standards for brain organoid research and therapy is feasible and advisable. …

Zustand: New. In English.

Zustand: New. In English.

Zustand: New. In English.

Zustand: New. In English.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume elucidates the pivotal ethical and legal issues arising from the use of brain organoids for research, therapeutic and enhancement purposes.The function of the human brain is still a mystery. Until recently, only post-mortem tissue was available for a structural examination of the brain. Consequently, the examination results could only reflect the state at the end of life. However, in order to better understand the development and function of the human brain, dynamic and functional investigations of different human brain cells are necessary. This is where brain organoids, artificially grown in vitro miniature brains, provide the opportunity for more flexible research scenarios.At the same time, however, the use of brain organoids in research and therapy raises the question of how these new entities are to be treated from an ethical and legal point of view. Against this background, this volume aims at clarifying the normative implications of the use of brain organoids in research and therapy. The ethical reflections on the status of brain organoids, informed consent, human-to-animal chimeras and neuro-enhancement are mirrored by corresponding legal analyses. The ethical and legal assessments are preceded by an introduction to the scientific and medical background of the brain organoid technology. A final chapter will be devoted to the issue of whether international harmonization of normative standards for brain organoid research and therapy is feasible and advisable.…

Taschenbuch. Zustand: Neu. Regulation of Genome Editing in Human iPS Cells | A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies | Hans-Georg Dederer (u. a.) | Taschenbuch | x | Englisch | 2023 | Springer | EAN 9783030930257 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Taschenbuch. Zustand: Neu. Regulation of Genome Editing in Plant Biotechnology | A Comparative Analysis of Regulatory Frameworks of Selected Countries and the EU | Hans-Georg Dederer (u. a.) | Taschenbuch | xi | Englisch | 2020 | Springer | EAN 9783030171216 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibilities for the treatment of hereditary diseases in humans. The treatment of such often severe but hitherto uncurable diseases can be based on genome-edited induced pluripotent stem cells (iPS cells). Such treatments constitute combined cell/gene therapies. These therapies need to be governed by a regulatory framework which ensures quality, safety, and efficacy of the relevant therapeutic products. On the other hand, such regulations may retard product approval and impede R&D. Accordingly, national regulations for therapies based on genome-edited iPS cells are an important and, as the case may be, decisive factor for both researchers and industry regarding their decision where to locate their R&D activities. Therefore, regulatory frameworks impact significantly on the competitiveness of states and their economies. This is why a comparative analysis of laws and regulations of different countries matters. Such a comparative legal analysis provides an important insight into regulatory concepts which, in turn, may inspire adjustments of, or amendments to, domestic legal regimes. For this purpose, experts present country reports on France, Germany, Japan, South Korea, Switzerland, and the USA. The reports on France and Germany also refer to the parameters and implications arising from pertinent EU law. This contributed volume is aimed at researchers, but also at, e.g., legal scholars, lawmakers, regulators, and political decision makers.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibilities for the treatment of hereditary diseases in humans. The treatment of such often severe but hitherto uncurable diseases can be based on genome-edited induced pluripotent stem cells (iPS cells). Such treatments constitute combined cell/gene therapies. These therapies need to be governed by a regulatory framework which ensures quality, safety, and efficacy of the relevant therapeutic products. On the other hand, such regulations may retard product approval and impede R&D. Accordingly, national regulations for therapies based on genome-edited iPS cells are an important and, as the case may be, decisive factor for both researchers and industry regarding their decision where to locate their R&D activities. Therefore, regulatory frameworks impact significantly on the competitiveness of states and their economies. This is why a comparative analysis of laws and regulations of different countries matters. Such a comparative legal analysis provides an important insight into regulatory concepts which, in turn, may inspire adjustments of, or amendments to, domestic legal regimes. For this purpose, experts present country reports on France, Germany, Japan, South Korea, Switzerland, and the USA. The reports on France and Germany also refer to the parameters and implications arising from pertinent EU law. This contributed volume is aimed at researchers, but also at, e.g., legal scholars, lawmakers, regulators, and political decision makers.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides in-depth insights into the regulatory frameworks of five countries and the EU concerning the regulation of genome edited plants. The country reports form the basis for a comparative analysis of the various national regulations governing genetically modified organisms (GMOs) in general and genome edited plants in particular, as well as the underlying regulatory approaches. The reports, which focus on the regulatory status quo of genome edited plants in Argentina, Australia, Canada, the EU, Japan and the USA, were written by distinguished experts following a uniform structure. On this basis, the legal frameworks are compared in order to foster a rational assessment of which approaches could be drawn upon to adjust, or to completely realign, the current EU regime for GMOs. In addition, a separate chapter identifies potential best practices for the regulation of plants derived from genome editing.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides in-depth insights into the regulatory frameworks of five countries and the EU concerning the regulation of genome edited plants. The country reports form the basis for a comparative analysis of the various national regulations governing genetically modified organisms (GMOs) in general and genome edited plants in particular, as well as the underlying regulatory approaches.The reports, which focus on the regulatory status quo of genome edited plants in Argentina, Australia, Canada, the EU, Japan and the USA, were written by distinguished experts following a uniform structure. On this basis, the legal frameworks are compared in order to foster a rational assessment of which approaches could be drawn upon to adjust, or to completely realign, the current EU regime for GMOs. In addition, a separate chapter identifies potential best practices for the regulation of plants derived from genome editing.…

Paperback. Zustand: Brand New. 344 pages. 9.25x6.10x0.72 inches. In Stock.

Hardcover. Zustand: Brand New. 372 pages. 9.50x6.25x1.00 inches. In Stock.

Zustand: New.

Zustand: New.

Taschenbuch. Zustand: Gut. 11., neu bearbeitete Auflage 2016. 393 S. Innerhalb Deutschlands Versand je nach Größe/Gewicht als Großbrief bzw. Bücher- und Warensendung mit der Post oder per DHL. Rechnung mit MwSt.-Ausweis liegt jeder Lieferung bei. Sprache: Deutsch Gewicht in Gramm: 660.

Zustand: Wie Neu. Zustandsbeschreibung: leichte Lagerspuren. Zur normativen Bewertung von totipotenten menschlichen Zellen. Hrsg. von Thomas Heinemann, Hans-Georg Dederer und Tobias Cantz. Vor dem Hintergrund der naturwissenschaftlichen Darstellung des historischen Konzepts und der aktuellen Begriffsbedeutung von entwicklungsbiologischer Totipotenz, analysieren die 10 rechtswissenschaftlichen Beiträge u.a., inwieweit Totipotenz ein adäquates oder ergänzungsbedürftiges Kriterium für die Legaldefinition des Embryos darstellt. Im Anschluss reflektiert der philosophische Teil den Embryobegriff unter den Aspekten der Potentialität, Natürlichkeit und Zweckbestimmungen. Mit Beiträgen von Jens Kersten, Geert Keil, Heike Baranzke, Barbara Advena-Regnery, Susan Sgodda, Michael Ott, Lena Laimböck, Franziska Enghofer, Benjamin Jung, Tobias Endrich und Katharina Böhm. 313 Seiten mit drei Abb., gebunden (V&R unipress 2015). Statt EUR 55,00. Gewicht: 595 g - Gebunden/Gebundene Ausgabe.…

kart. Zustand: Sehr gut. XXIII, 382 S. ; 24 cm Einband mit leichten Lagerspuren, sonst sehr gut erhalten. No shipping to other EU countries due to the EU Packaging and Packaging Waste Regulation (PPWR), which entered into force on August 12, 2026. Sprache: Deutsch Gewicht in Gramm: 635.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Gr.-8°, Brosch. XVI, 170 S. Neuwertiges Ex. / Fine Copy // Digitalisierung sowie Big-Data- und IT-Technologien durchdringen in rasantem Tempo und immer tiefer alle Bereiche der Gesellschaft. Sie haben zugleich der Erforschung und Anwendung von Systemen Künstlicher Intelligenz (KI) einen massiven Schub verliehen. Mit disruptiver Kraft formen sie die »Digitalgesellschaft« und schaffen damit neue normative Problemlagen. Die Beiträge dieses Tagungsbandes untersuchen, ob und wie das geltende Recht diese Herausforderungen bewältigen kann. Die dabei auftretenden Rechtsfragen führen vielfach über das positive Recht hinaus in die historischen, philosophischen und theoretischen Grundlagen des Rechts. Die Autoren diskutieren aktuelle Problemstellungen auf den Gebieten des Bürgerlichen Rechts, namentlich des Vertrags- und Deliktsrechts, des Arbeitsrechts und des Urheberrechts sowie des Strafprozessrechts und des Völkerrechts. ISBN: 9783161600487 Sprache: Deutsch Gewicht in Gramm: 294.…

Broschur : sehr guter Zustand, X, 259 Seiten, Literaturangaben ; 21 x 15 cm 500 g. Sprache: Deutsch.